Quinoxaline derivatives seem to have very interesting biological properties (1-3). The plant alkaloid ellipticine (5,11-dimethyl-6H-pyrido[4,3-b]carbazole) has DNA-intercalating and antitumor activity and is active against the herpes simplex virus (4, 5). Graslund et al. (6) have studied ellipticine and the derivatives 2,3-dimethyl-6-(2-dimethyl-aminoethyl)6H-indolo[2,3-b]quinoxaline and 6-(2-dimethylaminoethyl)6H-indolo [2,3-b] quinoxaline for their interaction with oligodeoxynucleotide duplexes. They reported that compounds were intercalated in a non-specific fashion and by an AT-specific interaction.
Some quinoxalin-2-ones have shown antifungal activity (10, 11) whereas quinoxalin--1-oxides have antibacterial activity (12) . 6H-indolo [2,3-b] quinoxaline can be regarded as an aza analogue of ellipticine. It was therefore of interest to test 6,9-disubstituted-6H--indolo [2,3-b] quinoxalines for their anticancer and cytostatic activity.
EXPERIMENTAL
Melting points were determined in open capillaries and were uncorrected. R f values were obtained using silica gel thin layer chromatography plates and a solvent system of chloroform/methanol (9:1). 2,3-Dioxy-2,3-dihydroindoles/5-substituted 2,3-dioxy-2,3--dihydroindoles and 1-(4-substituted)arylmethyl-2,3-dioxy-2,3-dihydroindoles were prepared according to literature (13, 14) . The infrared spectra of all compounds were determined by a diffuse reflectance technique using potassium bromide powder on a Jasco 460 FTIR machine (Jasco, Japan). 13 C NMR for 5i and 5j and 1 H NMR spectra (400 MHz) of all compounds were generated in dimethylsulfoxide-d 6 /CDCl 3 on a Bruker Ultraspec spectrophotometer (Germany). FAB mass spectra for 5c and 5j were obtained by using a Jeol SX-102 instrument (Jeol, Japan). CHN for all compounds were generated on an elemental analyzer Vario EL III (Germany). 
General procedure for the synthesis of 6-aralkyl-9-substituted-6H-indolo[2,3-b]quinoxalines (5a-m)
A mixture of 1-arylmethyl-2,3-dioxy-2,3-dihydroindole (0.005 mol), orthophenylene diamine (0.005 mol), glacial acetic acid (0.5-1.0 mL) and anhydrous ethanol (100 mL) was heated under reflux until the reaction was complete (4 h). Approximately half of the ethanol was removed in vacuo and the solution was left overnight at room temperature. The solid that precipitated was collected, washed with cold ethanol and recrystallized from suitable solvent. Products obtained were: 9-fluoro-6-(4-fluorobenzyl)-6H-indolo [2,3- 
Physico-chemical data for synthesized compounds 5a-m are reported in Table I .
Anticancer activity
Compounds 5b, 5d, 5g and 5l were submitted to in vitro disease-oriented antitumor screen (15) . This assay involves determination of a test agent's effect on growth parameters against a panel of approximately 60 human tumor cell lines, derived largely from solid tumors, including non-small cell lung, colon, central nervous system, melanoma, ovarian, prostate and breast cancers, plus a few leukemia and renal cell lines. Compounds were tested at a 1.0´10 -5 mol L -1 using DMSO as solvent; a 48-h continuous drug exposure protocol was applied and a sulforhodamine B (SRB) protein assay was used to estimate cell viability or growth. The measured effect of the compound on a cell line was calculated according to one of the following two expressions: if
where, A tzero is the average of absorbance measurements of SRB-derived color just before exposure of cells to the test compound, A test is the average absorbance measurements of SRB-derived color just after 48-h exposure of cells to the test compound, A ctrl is the average of absorbance measurements of SRB-derived color just after 48 h with no exposure of cells to the test compound.
Cytostatic activity
The methodology for cytostatic activity assays in Molt 4/C8, CEM and L1210 assays has been published previously (16) . In brief, varying concentrations of compounds were incubated at 37°C with the cells for 72 h (human Molt 4/C8 or CEM T-lymphocytes) or 48 h (murine L1210 cells). After the incubation period cell number was counted by a coulter counter (Harpenden Herz, UK).
RESULTS AND DISCUSSION
We have synthesized a series of thirteen derivatives of 6H-indolo [2,3-b] quinoxalines (5a-m) containing an N-aralkyl group at the 6 th position by reacting N-aralkylisatin with orthophenylene diamine, as depicted in Scheme I. The reaction of isatin with orthophenylene diamine has been reported to give spirobenzimidazoline, isatin-3-imine and/or 6H--indolo [2,3- were detected. Compounds 5a-m showed absorption bands ranging from 3052-3000 cm -1 for C-H aromatic stretching, 2960-2900 cm -1 for C-H aliphatic stretching; there were also some bands for C=C and C=N at 1580-1575 cm -1 and 1505-1480 cm -1 , respectively (Table  II) . In 1 H NMR spectra, the presence of a singlet between d 5.8-5.6 ppm was observed for the methylene group and multiplets were observed between d 8.55-7.00 ppm for aromatic protons. In the 13 C NMR spectra, signals from d 142.73 to 111.72 ppm were observed for aromatic carbon and d 44.90 to 21.12 ppm for alkyl carbons. Fast atomic bombardment (FAB) mass spectra showed accurate molecular ion peaks at m/z 338 and 357 for 5c and 5j, respectively (Table II) .
The anti-cancer activity of compounds 5b, 5d, 5g and 5l at concentrations 1.0´10 -5 mol L -1 was tested against 59 human tumor cell lines representing leukemia, melanoma and cancers of the lung, colon, brain, ovary, breast, prostate and kidney. The data for anticancer activity, in terms of the percent growth of treated cells, is given in Table III. Synthesized compounds and melphalan as a standard were also evaluated for their in vitro cytostatic activity against human Molt 4/C8 and CEM T-lymphocytes as well as murine leukemia L1210 cells. The results of cytostatic activity are presented in Table IV .
Only melphalan showed IC 50 values consistently lower than 10 mmol L -1 (IC 50 range 2.1-3.2 mmol L -1 ). The test compounds had IC 50 values ranging between 23 and ³ 1465 mmol L -1 (except for 5i that had and IC 50 of 7.2 mmol L -1 for L1210 cell proliferation). Compound 5h emerged as the only compound that consistently inhibited cell proliferation of all three tumor cell lines at an IC 50 ranging between 71 and 117 mmol L -1 . It is unclear why 5i is markedly more cytostatic to L1210 cells than to the human lymphocyte cell lines. Also, for 5e, 5j, 5k, 5l and 5m, there was a clear trend of higher cytostatic activity against the murine L1210 than against the human lymphocyte cell lines.
Structure activity relation
Quinoxaline derivatives with substituents like F and CH 3 on benzyl at 4 th position and F, CH 3 , Cl, Br at 9 th position exhibited anticancer activity against various cell lines of HOP-92, HCT-116, IGROV1, K-562 Molt-4 and RPMI-8226. The order of potency was found to be 5l > 5b > 5d ³ 5g as it is evident from the overall percentage of growth inhibition. In addition, compound 5l is selective against prostate cancer.
Quinoxaline derivatives with substituents like F and CH 3 on 4-aralkyl at 6 th position and Cl, F, Br and CH 3 at 9 th position were studied for cytostatic activity against human Molt 4/C8 and CEM T-lymphocytes as well as murine L1210 leukemia cells. In most cases, there was a more pronounced cytostatic activity against the murine leukemia L1210 cells than against the human lymphocyte cells. Among the tested compounds 5b, 5e, 5f, 5h, 5i, 5j and 5k were moderately cytostatic for the leukemia cell line L1210, as it is evident from Table IV (IC 50 < 100 mmol L -1 ). The order of cytostatic activity for L1210 was 5i > 5f ³ 5b, therefore it suggests that by placing a halogen like bromine on the ninth position and a methyl on the 4 th position of aralkyl on the 6 th position of quinoxaline produced compounds which were less cytostatic than the standard melphalan. By keeping the electron donating groups like methyl on 6 and 9 th position of aralkyl, there was not any improvement of cytostatic activity (5c).
CONCLUSIONS
The reaction of 5-substituted isatin with orthophenylene diamine provided the corresponding quinoxalines 5a-m in good yields. Investigations of cytostatic activities revealed better cytostatic activity of several compounds (5b, 5e, 5f, 5i, 5j, 5k, 5m) against the leukemia cell line L1210 than the human lymphocytic cell lines (the lowest IC 50 of 7.2 mmol L -1 was noted for 5i) compared to melphalan (IC 50 2.1 mmol L -1 ).
